XERIS BIOPHARMA HOLDINGS INC shareholders Q3 2023

XERIS BIOPHARMA HOLDINGS INC's ticker is and the CUSIP is 98422E103. A total of 111 filers reported holding XERIS BIOPHARMA HOLDINGS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.4%.

XERIS BIOPHARMA HOLDINGS INC shareholders Q3 2023
NameSharesValueWeighting ↓
IFP Advisors, Inc 200$3720.00%
OSAIC HOLDINGS, INC. 22,034$40,9830.00%
FMR LLC 9,292$17,2820.00%
Parallel Advisors, LLC 3,294$6,1270.00%
BANK OF AMERICA CORP /DE/ 69,787$129,8030.00%
Russell Investments Group, Ltd. 119$2210.00%
WELLS FARGO & COMPANY/MN 36,989$68,8000.00%
NORTHERN TRUST CORP 1,145,217$2,130,1040.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 55,742$103,6800.00%
GROUP ONE TRADING, L.P. 66,170$123,0760.00%
Legal & General Group Plc 15,335$28,5230.00%
ROYAL BANK OF CANADA 22,797$43,0000.00%
STATE STREET CORP 2,570,122$4,780,4270.00%
SG Americas Securities, LLC 18,363$340.00%

This page lists XERIS BIOPHARMA HOLDINGS INC's shareholders in Q3 2023. To view XERIS BIOPHARMA HOLDINGS INC's shareholder history, click here.